Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Retsas

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
Archiv Der Pharmazie|January 1, 1990
Lipophilicity of some substituted morpholine derivatives synthesized as potential antinociceptive agentsE Rekka, S Retsas, V J Demopoulos, et al.
Cancer|January 15, 1983
Evaluation of human lymphoblastoid interferon in advanced malignant melanomaS Retsas, T J Priestman, K A Newton, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 26, 2001
What is the optimal therapy of brain metastases?Y Marcou, C Lindquist, C Adams, et al.
European Journal of Cancer (Oxford, England : 1990)|March 1, 1997
In vitro synergy of paclitaxel (Taxol) and vinorelbine (navelbine) against human melanoma cell linesA Photiou, P Shah, L K Leong, et al.
Clinical Oncology|March 1, 1978
The importance of dose of thymosin for the in vitro induction of T-lymphocytes from patients with solid tumoursN A Byrom, S Retsas, A J Dean, et al.
Melanoma Research|September 30, 1999
Detection of tyrosinase mRNA by RT-PCR in the peripheral blood of patients with advanced metastatic melanomaJ P Alao, M Q Mohammed, M J Slade, et al.
Lancet (London, England)|March 17, 1979
Heredopathia atactica polyneuritiformis (refsum's disease) treated by diet and plasma-exchangeF B Gibberd, J D Billimoria, N G Page, et al.
Lancet (London, England)|August 5, 1978
Agranulocytosis in breast-cancer patients treated with levamisoleS Retsas, R H Phillips, I W Hanham, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 1, 1991
Ondansetron; further progress in the prevention of nausea and vomiting induced by anti-cancer chemotherapyS M Sagar, M A Bayliss, S L Chong, et al.
Medical Oncology (Northwood, London, England)|January 10, 2002
Serum S100beta protein as a marker of disease activity in patients with malignant melanomaM Q Mohammed, H D Abraha, R A Sherwood, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Archiv Der Pharmazie|January 1, 1990
Lipophilicity of some substituted morpholine derivatives synthesized as potential antinociceptive agentsE Rekka, S Retsas, V J Demopoulos, et al.
Cancer|January 15, 1983
Evaluation of human lymphoblastoid interferon in advanced malignant melanomaS Retsas, T J Priestman, K A Newton, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 26, 2001
What is the optimal therapy of brain metastases?Y Marcou, C Lindquist, C Adams, et al.
European Journal of Cancer (Oxford, England : 1990)|March 1, 1997
In vitro synergy of paclitaxel (Taxol) and vinorelbine (navelbine) against human melanoma cell linesA Photiou, P Shah, L K Leong, et al.
Clinical Oncology|March 1, 1978
The importance of dose of thymosin for the in vitro induction of T-lymphocytes from patients with solid tumoursN A Byrom, S Retsas, A J Dean, et al.
Melanoma Research|September 30, 1999
Detection of tyrosinase mRNA by RT-PCR in the peripheral blood of patients with advanced metastatic melanomaJ P Alao, M Q Mohammed, M J Slade, et al.
Lancet (London, England)|March 17, 1979
Heredopathia atactica polyneuritiformis (refsum's disease) treated by diet and plasma-exchangeF B Gibberd, J D Billimoria, N G Page, et al.
Lancet (London, England)|August 5, 1978
Agranulocytosis in breast-cancer patients treated with levamisoleS Retsas, R H Phillips, I W Hanham, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 1, 1991
Ondansetron; further progress in the prevention of nausea and vomiting induced by anti-cancer chemotherapyS M Sagar, M A Bayliss, S L Chong, et al.
Medical Oncology (Northwood, London, England)|January 10, 2002
Serum S100beta protein as a marker of disease activity in patients with malignant melanomaM Q Mohammed, H D Abraha, R A Sherwood, et al.
Pageof 7